Clinical Trial Update: Escitalopram and Language Intervention for Subacute Aphasia [Phase 2]

View source ↗

Summary

This Phase 2 trial from Johns Hopkins is evaluating escitalopram plus a language intervention for subacute aphasia after stroke and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aphasia
• Stroke

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: Johns Hopkins University | Conditions: Aphasia, Stroke | Phase 2 | Status: RECRUITING